The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ PeptideTherapeuticsMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandForecast 2023-2028
” " the global peptide therapeutics market reached a value of US$ 39.2 Billion in 2022.
Peptides refer to naturally occurring, short chains of amino acid monomers that are connected with cell surface receptors for triggering intracellular effects. They are extremely small, versatile, and offer higher efficacy than other clinical practices; therefore, they are extensively used for engineering novel regenerative medications as they can target varying cells and manipulate their reactions.
Along with this, peptide therapeutics are non-toxic, well-tolerated, and offer anti-inflammatory properties, which help in improving the immune system, repairing muscle tendons, and acting as an antioxidant for treating several metabolic disorders. Consequently, they are being employed for managing cancer, injuries, aesthetic concerns, and multiple infectious diseases.
Request Free Sample Report: https://www.imarcgroup.com/peptide-therapeutics-market/requestsample
With the increasing prevalence of various chronic and metabolic disorders, especially amongst the geriatric population, there has been a rising need for effective medications, which in turn, has facilitated the widespread adoption of peptide therapeutics across the healthcare sector for treatment purposes. Additionally, the rising consciousness amongst consumers regarding their physical appearance has supplemented the utilization of peptide therapeutics in cosmeceutical surgeries as they slow down the aging process, which is acting as another growthinducing factor. In line with this, extensive investments being made by governments of several countries in pharmaceutical companies to develop innovative novel peptide medications and synthetic strategies to improve product stability are contributing to the market growth.
Moreover, escalating awareness amongst individuals regarding the availability of personalized medicines and the ongoing clinical trials by healthcare professionals to develop and execute precise non-invasive treatment procedures to treat autoimmune and inflammatory diseases are impelling the market growth. Other factors, such as the significant expansion in the healthcare infrastructure and continuous research and development (R&D) activities to engineer multi-purpose peptide-based materials, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 66.1 Billion by 2028, growing at a CAGR of 9% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
MarketSummary:
BreakupbyType:
• Innovative
• Generic
BreakupbyTypeofManufacturer:
• Outsourced
• In-house
BreakupbySynthesisTechnology:
• Solid Phase Peptide Synthesis
• Liquid Phase Peptide Synthesis
• Hybrid Technology
BreakupbyRoutesofAdministration:
• Parenteral
• Oral
• Others
BreakupbyApplication:
• Gastrointestinal Disorders
• Neurological Disorders
• Metabolic Disorders
• Cancer
• Others
BreakupbyRegion:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
CompetitiveLandscapewithKeyPlayers:
• Amgen Inc
• Apitope International NV
• Arch Biopartners Inc.
• AstraZeneca plc
• Circle Pharma Inc.
• Corden Pharma GmbH
• F. Hoffmann-La Roche AG
• Ipsen Group
• Lonza Group AG
• Novo Nordisk A/S
• Pfizer Inc.
• Teva Pharmaceuticals Industries Ltd.
• Zealand Pharma A/S
ViewFullReportwithTOC&ListofFigure:
https://www.imarcgroup.com/peptide-therapeutics-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
